Adam Bisaga, MD
New York State Psychiatric Institute · Columbia University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Adam Bisaga, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 20:38 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05382091 · Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent PersonsGo Medical Industries Pty Ltd · not yet recruiting · Opioid Use Disorder · principal investigator
- Ph2/Ph3NCT05011266 · Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use DisorderNew York State Psychiatric Institute · recruiting · Opioid-use Disorder · principal investigator
- Ph1NCT04716881 · Pharmacokinetic Study of Vivitrol in Healthy ParticipantsGo Medical Industries Pty Ltd · completed · Opioid-use Disorder · principal investigator
- Ph1NCT03810495 · The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy VolunteersGo Medical Industries Pty Ltd · completed · Opioid Use Disorder · principal investigator
- Ph2/Ph3NCT01024335 · Dronabinol Naltrexone Treatment for Opioid DependenceNew York State Psychiatric Institute · completed · Opioid Dependence · principal investigator
- Ph2NCT00731055 · Effects of Varenicline on Cigarette Self AdministrationNew York State Psychiatric Institute · completed · Nicotine Dependence · principal investigator
- Ph2/Ph3NCT00476242 · Memantine as a Supplement to Naltrexone in Treating Heroin DependenceNew York State Psychiatric Institute · completed · Opioid Dependence, Heroin Dependence · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 20:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Evaluation of safety and pharmacokinetics of naltrexone implantUH3DA047720 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI ADAM BISAGA, Edward V. Nunes · fiscal years 2021 to 2023Named on NCT05382091
- Efficacy of buprenorphine and XR-naltrexone combination for relapse prevention in opioid use disorderU01DA046430 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI ADAM BISAGA · fiscal years 2020 to 2026Named on NCT05011266
- Evaluation of safety and pharmacokinetics of naltrexone implantUG3DA047720 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI ADAM BISAGA, Edward V. Nunes · fiscal years 2018 to 2019Named on NCT04716881, NCT03810495
- Dronabinol naltrexone treatment for opioid dependenceR01DA027124 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ADAM BISAGA · fiscal years 2009 to 2010Named on NCT01024335
- Developing Medication For Tobacco Addiction: NMDA AgentsR01DA017572 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI ADAM BISAGA · fiscal years 2003 to 2007Named on NCT00731055
- Memantine Naltrexone Treatment for Opioid DependenceR01DA015822 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI ADAM BISAGA · fiscal years 2005 to 2009Named on NCT00476242
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.